Impact of rectal washout on bacterial contamination caused by transrectal access for natural-orifice transluminal endoscopic surgery (NOTES)

ISRCTN ISRCTN70107172
DOI https://doi.org/10.1186/ISRCTN70107172
Secondary identifying numbers N/A
Submission date
05/10/2011
Registration date
15/11/2011
Last edited
15/11/2011
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Surgery
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Beat Mueller
Scientific

Klinik für Allgemein-, Viszeral- und Transplantationschirurgie
Universität Heidelberg
Im Neuenheimer Feld 110
Heidelberg
69120
Germany

Phone +49 (0) 6221 56 8641
Email beat.mueller@med.uni-heidelberg.de

Study information

Study designProspective randomized controlled patient-blinded surgical trial with three parallel study groups
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleImpact of rectal washout on bacterial contamination caused by transrectal access for natural-orifice transluminal endoscopic surgery (NOTES): a randomized controlled trial
Study acronymNOBACT II
Study objectivesThe null-hypothesis states that the probability of bacterial contamination caused by transrectal access measured by a swab of the circular stapler’s center rod is the same for experimental intervention and control intervention. The alternative hypothesis states that the experimental interventions and the control intervention perform differently in terms of primary efficacy endpoint.
Ethics approval(s)Ethics Committee of the University of Heidelberg approved on 25/05/2011, (ref: S-396/2010)
Health condition(s) or problem(s) studiedPatients undergoing sigmoid resection or left hemicolectomy
InterventionExperimental intervention:
1. Rectal washout with 5% povidon iodine using an applicator
2. Rectal washout with sodium chloride (NaCl) using an applicator

Control intervention:
Rectal washout with NaCl using an irrigation syringe
Intervention typeDrug
Pharmaceutical study type(s)
PhaseNot Applicable
Drug / device / biological / vaccine name(s)5% povidon iodine
Primary outcome measureBacterial contamination at the circular stapler’s center rod following experimental intervention (rectal washout with 5% povidone iodine using an applicator) and control intervention
Secondary outcome measures1. Bacterial contamination at the circular stapler’s center rod following experimental intervention (rectal washout with NaCl using an applicator)
2. Bacterial count and routine cultures at rectal mucosa, center rod, small pelvis
3. Exploratory analyses
Overall study start date01/12/2011
Completion date01/12/2012

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants69
Key inclusion criteria1. Given indication for sigmoid resection or left hemicolectomy with primary anastomosis in the proximal rectum
2. Age > 18 years
3. Written informed consent
Key exclusion criteria1. American Society of Anesthesiology patient (ASA) classification IV and V
2. Emergency operation (obstruction, bleeding, peritonitis)
3. Hand-sutured anastomosis
4. Ileus, colitis, pelvic infection
5. Reoperation
6. Anastomosis < 6cm from the anus
7. Ongoing antibiotic therapy
8. Iodine allergy
9. Hyperthyreosis
Date of first enrolment01/12/2011
Date of final enrolment01/12/2012

Locations

Countries of recruitment

  • Germany

Study participating centre

Klinik für Allgemein-, Viszeral- und Transplantationschirurgie
Heidelberg
69120
Germany

Sponsor information

University of Heidelberg (Germany)
University/education

Klinik für Allgemein-, Viszeral- und Transplantationschirurgie
Universität Heidelberg
Im Neuenheimer Feld 110
Heidelberg
69120
Germany

Email markus.buechler@med.uni-heidelberg.de
Website http://www.uni-heidelberg.de/index_e.html
ROR logo "ROR" https://ror.org/038t36y30

Funders

Funder type

University/education

University of Heidelberg (Germany)
Government organisation / Universities (academic only)
Alternative name(s)
University of Heidelberg, Ruprecht-Karls-Universität Heidelberg
Location
Germany

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan